Regulus Therapeutics Inc.
(RGLS)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -30.04M | -28.32M | -27.81M | -15.73M | -18.59M | -48.71M | -71.91M | -81.84M | -55.75M | -56.68M | -18.67M | -17.41M | -7.60M | -15.56M |
| Depreciation & Amortization | 227.00K | 122.00K | 459.00K | 467.00K | 931.00K | 2.26M | 2.52M | 2.28M | 1.59M | 1.49M | 1.36M | 1.02M | 911.00K | 494.00K |
| Stock-Based Compensation | 2.80M | 2.18M | 2.92M | 2.61M | 2.29M | 5.44M | 7.64M | 12.87M | 15.37M | 7.04M | 3.42M | 1.55M | 825.00K | 603.00K |
| Other Working Capital | 228.00K | 660.00K | 660.70K | 106.39K | -5.07M | 1.12M | 2.08M | -1.05M | -14.98M | -6.03M | -17.89M | 1.17M | -8.95M | 25.28M |
| Other Non-Cash Items | -16.00K | -52.00K | 46.00K | 154.00K | 2.13M | 756.00K | 600.00K | 1.04M | 18.65M | 8.64M | 4.89M | 1.97M | -7.60M | 518.00K |
| Deferred Income Tax | - | - | -662.00K | - | - | 148.00K | 349.00K | 666.00K | -15.27M | 5.10M | -2.30M | 3.17M | 8.15M | 394.00K |
| Change in Working Capital | 257.00K | 550.00K | 914.00K | -41.00K | -6.58M | -3.17M | 2.02M | 8.10M | -14.45M | -5.09M | -17.03M | 983.00K | -9.75M | 25.86M |
| Operating Cash Flow | -26.77M | -25.53M | -24.13M | -12.54M | -19.82M | -43.27M | -58.77M | -56.88M | -49.86M | -39.51M | -28.33M | -8.72M | -15.06M | 12.31M |
| Capital Expenditures | -613.00K | -361.00K | -251.00K | -11.00K | -244.00K | -22.00K | -319.00K | -966.00K | -1.43M | -1.21M | -835.00K | -1.43M | -598.00K | -2.42M |
| Acquisitions | - | 14.76K | - | - | 318.00K | - | 16.00K | 53.00K | 67.00K | 65.00K | 35.00K | 275.00K | 131.00K | 531.00K |
| Purchase of Investments | -4.90M | -32.76M | - | - | - | - | -55.69M | -65.11M | -78.40M | -113.42M | -72.00M | -62.04M | -50.66M | -43.48M |
| Sales Maturities Of Investments | 20.00M | 18.00M | - | - | - | 46.54M | 69.94M | 101.39M | 101.31M | 85.42M | 31.95M | 33.08M | 54.59M | 23.93M |
| Other Investing Acitivies | 3.00K | -14.76K | - | -11 | 295.00 | 46.54M | -16.00K | -53.00K | -67.00K | -65.00K | -35.00K | -275.00K | -131.00K | -531.00K |
| Investing Cash Flow | 14.49M | -15.12M | -251.00K | -11.00K | 74.00K | 46.52M | 13.94M | 35.31M | 21.48M | -29.21M | -40.89M | -30.38M | 3.32M | -21.96M |
| Debt Repayment | -3.30M | - | -80.00K | -9.62M | -2.24M | -3.05M | - | 19.60M | - | - | - | 5.00M | - | 4.69M |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 15.12M | - | 26.00K | 5.00K | 3.00K | 1K | 4.00K | 310.00K | 6.53M | 88.24M | -100.00K | -445.00K | -412.00K | 10.00M |
| Financial Cash Flow | 11.82M | 4.49M | 53.74M | 9.51M | 39.93M | -2.83M | 43.41M | 20.55M | 7.02M | 88.24M | 46.47M | 70.48M | -354.00K | 14.69M |
| Net Cash Flow | -461.00K | -36.16M | 29.36M | -3.03M | 20.19M | 416.00K | -1.42M | -1.02M | -21.37M | 19.52M | -22.75M | 31.38M | -12.09M | 5.04M |
| Free Cash Flow | -27.38M | -25.89M | -24.38M | -12.55M | -20.07M | -43.30M | -59.09M | -57.85M | -51.29M | -40.72M | -29.16M | -10.15M | -15.66M | 9.89M |